HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a

Jun Hu1, Weili Ge2, Junfeng Xu3

  • 1Department of Prosthodontics, Hospital of Stomatology Affiliated to Zhejiang University, Hangzhou, 310006, People's Republic of China.

Insights

Human Papillomavirus type 16 E7 oncoprotein upregulates miR-20a, inhibiting oral squamous cell carcinoma (OSCC) cell proliferation, invasion, and migration. This study reveals a novel mechanism in OSCC development.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Oral squamous cell carcinoma (OSCC) is a prevalent cancer globally.
  • Human Papillomavirus type 16 (HPV-16) oncoproteins, particularly E7, are implicated in OSCC pathogenesis.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.

Purpose of the Study:

  • To investigate the role of HPV-16 E7 in regulating miR-20a expression.
  • To determine the effect of HPV-16 E7-mediated miR-20a upregulation on OSCC cell proliferation, invasion, and migration.

Main Methods:

  • Western blot and RT-PCR were used to detect HPV-16 E7 protein and miR-20a expression.
  • SiRNA was employed to inhibit HPV-16 E7, and plasmid transfection was used for its overexpression.
  • Cell proliferation was assessed using CCK-8 assay; invasion and migration were evaluated by Transwell and wound healing assays.

Main Results:

  • MiR-20a expression was significantly higher in OSCC tissues than in adjacent normal tissues.
  • HPV-16 E7 overexpression upregulated miR-20a, while its inhibition downregulated miR-20a.
  • Upregulation of miR-20a by HPV-16 E7 significantly inhibited OSCC cell proliferation, invasion, and migration.

Conclusions:

  • HPV-16 E7 promotes OSCC progression by upregulating miR-20a.
  • MiR-20a acts as a tumor suppressor in OSCC by inhibiting proliferation, invasion, and migration.
  • Targeting the HPV-16 E7/miR-20a axis may offer a therapeutic strategy for OSCC.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis02:30

Metastasis

3.8K